• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

45 分钟和 20 分钟输注后头皮冷却时间预防紫杉醇所致脱发的等效性-一项随机对照试验。

Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.

机构信息

Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, Leiden, 2300 RC Leiden, The Netherlands.

Department of Research & Development, The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.

出版信息

Support Care Cancer. 2022 Aug;30(8):6641-6648. doi: 10.1007/s00520-022-07090-7. Epub 2022 May 2.

DOI:10.1007/s00520-022-07090-7
PMID:35501515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9213299/
Abstract

PURPOSE

Scalp cooling can prevent chemotherapy-induced alopecia (CIA). Previously, the post-infusion cooling time (PICT) could be successfully reduced in docetaxel-treated patients from 90 to 45 and 20 min. Therefore, it seems plausible that the PICT can be shortened for paclitaxel-treated patients as well.

METHODS

Patients treated with weekly paclitaxel were included in this multi-centre trial and randomly assigned to a PICT of 45 or 20 min. The results were compared to a standard PICT of 90 min, derived from prospective collected data from the Dutch Scalp Cooling Registry. The primary endpoint was the percentage of patients who decide to not wear a wig or head covering. Secondary endpoints were the degree of CIA assessed with the Dean scale for assessment of hair loss; alopecia graded according to NCI CTC toxicity version 4.03 (CTCAE4.03); tolerance of scalp cooling and perceived distress of CIA.

RESULTS

Ninety-one patients were enrolled in this study; 74 patients were evaluable for hair loss. Hair preservation was successful in 27 patients (75%) with a PICT of 45 min and in 31 patients (82%) with a PICT of 20 min. There was no difference in success rate with the standard PICT of 90 min (85%, p = 0.29). Similar success rates were seen when using the Dean scale and CTCAE assessment, with no differences between groups (p = 0.12 and p = 0.38).

CONCLUSIONS

A 20 min PICT is as effective as 45 and 90 min to prevent weekly paclitaxel-induced alopecia and should be the new standard of care.

TRIAL REGISTER

ClinicalTrials.gov Identifier: NCT03266185.

摘要

目的

头皮冷却可预防化疗引起的脱发(CIA)。先前,在接受多西他赛治疗的患者中,输注后冷却时间(PICT)可成功从 90 分钟缩短至 45 分钟和 20 分钟。因此,对于接受紫杉醇治疗的患者,PICT 似乎也可以缩短。

方法

本多中心试验纳入接受每周紫杉醇治疗的患者,并随机分为 PICT 45 分钟或 20 分钟组。结果与来自荷兰头皮冷却登记处前瞻性收集数据的标准 PICT(90 分钟)进行比较。主要终点是决定不戴假发或头饰的患者比例。次要终点是使用脱发评估的 Dean 量表评估 CIA 的程度;根据 NCI CTC 毒性版本 4.03(CTCAE4.03)分级的脱发程度;头皮冷却的耐受性和 CIA 所致的痛苦程度。

结果

本研究纳入 91 例患者;74 例患者可评估脱发。45 分钟 PICT 组有 27 例(75%)患者头发保留成功,20 分钟 PICT 组有 31 例(82%)患者头发保留成功。标准 90 分钟 PICT 的成功率无差异(85%,p=0.29)。使用 Dean 量表和 CTCAE 评估时,成功率相似,组间无差异(p=0.12 和 p=0.38)。

结论

20 分钟 PICT 与 45 分钟和 90 分钟一样有效,可预防每周紫杉醇引起的脱发,应成为新的护理标准。

试验注册

ClinicalTrials.gov 标识符:NCT03266185。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7bd/9213299/616cbd061224/520_2022_7090_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7bd/9213299/c13adff003fc/520_2022_7090_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7bd/9213299/616cbd061224/520_2022_7090_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7bd/9213299/c13adff003fc/520_2022_7090_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7bd/9213299/616cbd061224/520_2022_7090_Fig2_HTML.jpg

相似文献

1
Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.45 分钟和 20 分钟输注后头皮冷却时间预防紫杉醇所致脱发的等效性-一项随机对照试验。
Support Care Cancer. 2022 Aug;30(8):6641-6648. doi: 10.1007/s00520-022-07090-7. Epub 2022 May 2.
2
Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.输注后20分钟与45分钟头皮冷却时间对预防多西他赛所致脱发的效果
Support Care Cancer. 2016 Jun;24(6):2735-41. doi: 10.1007/s00520-016-3084-7. Epub 2016 Jan 25.
3
Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.延长输注后头皮冷却持续时间预防蒽环类药物引起的脱发:辅助化疗治疗乳腺癌患者的随机试验。
Support Care Cancer. 2019 May;27(5):1919-1925. doi: 10.1007/s00520-018-4432-6. Epub 2018 Sep 11.
4
Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry.湿发对预防癌症患者化疗所致脱发的作用甚微——荷兰头皮冷却登记研究结果。
Support Care Cancer. 2023 Apr 17;31(5):273. doi: 10.1007/s00520-023-07687-6.
5
Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.输注后头皮冷却时间短可预防多西紫杉醇所致脱发。
Support Care Cancer. 2012 Dec;20(12):3255-60. doi: 10.1007/s00520-012-1465-0. Epub 2012 Apr 27.
6
Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.头皮冷却对接受多西他赛和环磷酰胺辅助化疗的乳腺癌患者预防化疗引起脱发的疗效
Clin Breast Cancer. 2015 Oct;15(5):332-4. doi: 10.1016/j.clbc.2015.01.003. Epub 2015 Jan 26.
7
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.头皮冷却装置对乳腺癌化疗女性脱发的影响:SCALP 随机临床试验。
JAMA. 2017 Feb 14;317(6):596-605. doi: 10.1001/jama.2016.20939.
8
Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.两种头皮冷却系统预防多西他赛治疗相关脱发的疗效和耐受性。
Support Care Cancer. 2013 Sep;21(9):2565-73. doi: 10.1007/s00520-013-1804-9. Epub 2013 May 2.
9
COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.COOLHAIR:一项前瞻性随机试验,旨在研究头皮冷却在接受早期乳腺癌新辅助化疗的患者中的疗效和耐受性。
Breast Cancer Res Treat. 2019 Jan;173(1):135-143. doi: 10.1007/s10549-018-4983-8. Epub 2018 Sep 25.
10
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.头皮冷却装置的使用与乳腺癌化疗后脱发之间的关联。
JAMA. 2017 Feb 14;317(6):606-614. doi: 10.1001/jama.2016.21038.

引用本文的文献

1
Shorter post-infusion cooling times at least as effective as longer cooling times - An observational study of taxane- and anthracycline-based chemotherapies in the Dutch Scalp Cooling Registry.输注后较短的冷却时间至少与较长的冷却时间同样有效——荷兰头皮冷却登记处中基于紫杉烷和蒽环类药物化疗的一项观察性研究。
Support Care Cancer. 2025 May 28;33(6):503. doi: 10.1007/s00520-025-09526-2.
2
Natural Taxanes: From Plant Composition to Human Pharmacology and Toxicity.天然紫杉烷类化合物:从植物组成到人体药理学和毒性。
Int J Mol Sci. 2022 Dec 9;23(24):15619. doi: 10.3390/ijms232415619.

本文引用的文献

1
[Allow scalp cooling during adjuvant chemotherapy in patients with breast cancer; scalp metastases rarely occur].[乳腺癌患者辅助化疗期间允许进行头皮冷却;头皮转移很少发生]
Ned Tijdschr Geneeskd. 2010;154:A2134.